Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials".
Rosenberg
Lauren
L
Uretsky
Seth
S
D000069059:Atorvastatin; D015415:Biomarkers; D052283:Creatine Kinase, MM Form / Q000097:blood; D006538:Heptanoic Acids / Q000009:adverse effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D009135:Muscular Diseases / Q000097:blood / Q000139:chemically induced* / Q000453:epidemiology; D010146:Pain / Q000097:blood / Q000139:chemically induced* / Q000453:epidemiology; D011758:Pyrroles / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012206:Rhabdomyolysis / Q000097:blood / Q000139:chemically induced* / Q000453:epidemiology
D015415:Biomarkers; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D052283:Creatine Kinase, MM Form